Summary
While several radiological findings point towards the basal ganglia as a possible anatomical site of the lesion in dystonia patients the biochemical basis of the disorder is still unknown. 5-Hydroxyindoleacetic acid (5-HIAA) and homovanillic acid (HVA) levels — the respective metabolites of serotonin and dopamine — were measured in lumbar cerebrospinal fluid (lCSF) of 15 patients with idiopathic adult-onset focal dystonia and in lCSF of 11 controls. 100 μl lCSF were analyzed for 5-HIAA and HVA by reversed-phase HPLC with electrochemical detection. 5-HIAA levels were significantly reduced in dystonia patients (11.4μg/ml) compared to controls (18.4ng/ml) (p < 0.02). HVA levels in dystonia patients (30.3ng/ml) were below control values (41.6ng/ml) but this finding did not reach statistical significance. Decreased lCSF levels of 5-HIAA suggest an impaired serotonin metabolism in patients with idiopathic adult-onset dystonia. This observation may provide a biochemical basis for a more specific pharmacotherapy in dystonia patients.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Adams L, Foote S (1988) Possible involvement of brain noradrenergic neurons in dystonia. Adv Neurol 50: 313–333
Banki CM, Vojnik M, Papp Z, Balla KZ, Arato M (1985) Cerebrospinal fluid magnesium and calcium related to amine metabolites, diagnosis, and suicide attempts. Biol Psychiatry 20: 163–171
Bertilsson L (1987) 5-Hydroxyindolacetic acid in cerebrospinal fluid —methodological and clinical aspects. Life Sci 41: 821–824
Black B, Uhde TW (1992) Acute dystonia and fluoxetine. J Clin Psychiatry 53: 327
Bodner RA, Lynch T, Lewis L, Kahn D (1995) Serotonin syndrome. Neurology 45: 219–223
Chase TN (1970) Biochemical and pharmacologie studies of dystonia. Neurology 20: 122–130
Cohen DJ, Shaywitz BA, Bowers MB (1979) Central biogenic amine metabolism in children with the syndrome of chronic multiple tics of Gilles de la Tourette. J Am Acad Child Psychiat 18: 320–342
Curzon G (1973) Involuntary movements other than parkinsonism: biochemical aspects. Proc Roy Soc Med 66: 873–876
Durif F, Vidailhet M, Bonnet AM, Blin J, Agid Y (1995) Levodopa-induced dyskinesias are improved by fluoxetine. Neurology 45: 1855–1858
Fahn S, Marsden CD, Calne DB (1987) Classification and investigation of dystonia, 2nd edn. Butterworth, London, pp 332–358
Garelis E, Sourkes TL (1973) Sites and origin in the central nervous system of monoamine metabolites in human cerebrospinal fluid. J Neurol Neurosurg Psychiatry 36: 625–6292
Hallett M (1993) Physiology of basal ganglia disorders: an overview. Can J Neurol Sci 20: 177–183
Hedreen JC, Zweig R, DeLong, Whitehouse PJ, Price DL (1988) Primary dystonias: a review of the pathology and suggestions for new directions of study. Adv Neurol 50: 123–132
Hornykiewicz O, Kish S, Backer L, Parley I, Shannak K (1986) Brain neurotransmitters in dystonia musculorum deformans. N Engl J Med 315: 247–353
Hornykiewicz O, Kish S, Becker L, Parley I, Shannak K (1988) Biochemical evidence for brain neurotransmitter changes in idiopathic torsion dystonia (dystonia musculorum deformans). Adv Neurol 50: 157–165
Humphrey PP, Hartig P, Hoyer D (1993) A proposed new nomenclature for 5-HT receptors. Trends Pharmacol Sci 14: 233–236
Jahanshahi M, Marsden CD (1988) Personality in torticollis: a controlled study. Psychol Med 18: 375–387
Jankovic J, Ford J (1983) Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 13: 402–411
Jankovic J, Svendsen C, Bird E (1987) Brain neurotransmitters dystonia. N Engl J Med 316: 278–279
Jankovic J, Schwartz K, Donovan DT (1990) Botulinum toxin treatment of cranialcervical dystonia, spasmodic dystonia, other focal dystonias and hemifacial spasm. J Neurol Neurosurg Psychiatry 53: 633–639
Lal S, Young SN, Kiely ME, Baxter DW, Sourkes TL (1981) Effect of L-tryptophan on spasmodic torticollis. Can J Neurol Sci 8: 305–308
Lance JW (1993) The pathophysiology of migraine, 6th edn. Oxford University Press, New York, pp 59–95
Maltese W, Bressmann S, Fahn S, De Vivo D (1985) Acetylcholinesterase activity in patients with torsion dystonia. Arch Neurol 45: 154–155
Marsden CD, Harrison MJG (1974) Idiopathic torsion dystonia (dystonia musculorum deformans). A review of fourty-two patients. Brain 97: 793–810
Marsden CD, Obeso JA, Zarranz JJ, Lang E (1985) The anatomical basis of symptomatic hemidystonia. Brain 108: 463–483
Mori K, Fujita Y, Shimabukuro H, Ito M, Handa H (1975) Some considerations for treatment of spasmodic torticollis. Clinical and experimental studies. Confinita Neurologica 37: 265–269
Perry TL, Hansen S, Quinn N, Marsden CD (1982) Concentrations of GABA and other amino acids in CSF from torsion dystonia patients. J Neurochem 39: 1188–1191
Post RM, Kotin J, Goodwin FK, Gordon EK (1973) Psychomotor activity and cerebrospinal fluid amine metabolites in affective illness. Am J Psychiatry 130: 67–72
van Praag HM (1980) Central monoamine metabolism in depression. Serotonin and related compounds. Compr Psychiatry 21: 30–43
Rothwell JC, Day BL, Marsden CD (1983) Pathophysiology of dystonia. Adv Neurol 39: 851–863
Ruhberg M, Villageois A, Bonnet AM, Rieger F, Agid Y, Fahn S (1988) Acetylcholinesterase and buturylcholinesterase in cerebrospinal fluid from patients with dystonia. Adv Neurol 50: 211–213
Schnider P, Wenzel T, Müller C, Wimmer A, Auff E (1994) Psychiatrie disorders in patients with torticollis or blepharospasm. Mov Disord 9 [Suppl 1]: 37
Shihabuddin L, Rapport D (1994) Sertraline and extrapyramidal side effects. Am J Psychiatry 151: 288
Sofic E, Riederer P, Schmidt B, Fritze J, Kollegger H, Dierks, Beckmann H (1992) Biogenic amines and metabolites in CSF from patients with HIV infection. Biogen Amines 8: 293–298
Soininen HS, MacDonald E, Rekonen M, Riekinen PJ (1981) HVA and 5-HIAA levels in CSF of patients with senile dementia of Alzheimer type. Acta Neurol Scand 64: 217–224
Stahl S, Berger P (1982) Bromocriptine, physostigmine, and neurotransmitter mechanism in the dystonias. Neurology 32: 889–892
Stanley M, Traskmann-Bendz L, Dorovini-Zis K (1985) Correlations between aminergic metabolites simultaneously obtained from human CSF and brain. Life Sci 37: 1279–1286
Steinbusch HWM, Nieuwenhuys R (1983) The raphe nuclei of the rat brainstam: a cytoarchitectonic and immunohistological study, 2nd edn. Raven Press, New York, p 131
Tabaddor K, Wolfson L, Sharpless N (1978) Diminished ventricular fluid dopamine metabolites in adult-onset dystonia. Neurology 28: 1254–1258
Tate JL (1989) Extrapyramidal symptoms in a patient taking haloperidol and fluoxetine. Am J Psychiatry 146: 399–400
Wagner J, Vitali MG, Palfreyman MH, Zraika M, Huot S (1982) Simultaneous determination of 3,4-dihydroxyphenylalanine, 5-hydroxytryptophan, dopamine, 4-hydroxy-3-methoxyphenylalanin, norepinephrine, 3,4-dihydroxyphenylacetic acid, homovanillic acid, serotonin and 5-hydroxyindolacetic acid in rat cerebrospinal fluid and brain by high performance liquid chromatography with electrochemical detection. J Neurochem 38: 1241–1254
Wolfson L, Sharpless N, Thal L, Waltz J, Shapiro K (1983) Decreased ventricular fluid norepinephrine metabolite in childhood-onset dystonia. Neurology 33: 369–372
Zambrino CA, Balottin U, Borgatti R, Lanzi G (1991) Considerations on two cases of dystonia-parkinsonism. Ital J Neurol Sci 12: 475–478
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Naumann, M., Götz, M., Reiners, K. et al. Neurotransmitters in CSF of idiopathic adult-onset dystonia: Reduced 5-HIAA levels as evidence of impaired serotonergic metabolism. J. Neural Transmission 103, 1083–1091 (1996). https://doi.org/10.1007/BF01291793
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01291793